Octean Pharma ApS: Financial statements 2025
CVR: 38023667
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Octean Pharma ApS (CVR 38023667) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -14,152 and a net result of DKK -15,398 compared with DKK 102,485 the year before. Equity in the 2025 report amounted to DKK 206,750. The solvency ratio was 19%.
- Gross Profit
- DKK -14,152
- Profit/Loss
- DKK -15,398
- Equity
- DKK 206,750
- Total Assets
- DKK 1,088,688
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -14 t. | -15 t. | 207 t. | 0 |
| 2024 | - | 130 t. | 102 t. | 222 t. | 0 |
| 2023 | - | 188 t. | 19 t. | 120 t. | 1 |
| 2022 | - | 571 t. | 11 t. | 101 t. | 1 |
| 2021 | - | 1.2 mio. | 43 t. | 90 t. | 1 |
Official annual report
How creditworthy is Octean Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Octean Pharma ApS has published its annual report for 2024. Gross profit came to DKK 130,227, and the net result was DKK 102,485.
About Octean Pharma ApS
Octean Pharma ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Detailhandel med andre fødevarer. The management consists of Lotte Johannesson. The company is owned by Halobid Aktiebolag. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -14,152 and a net result of DKK -15,398 compared with DKK 102,485 the year before. Equity in the 2025 report amounted to DKK 206,750.